Jane Street Group LLC Sells 235,032 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Jane Street Group LLC cut its stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 67.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 114,827 shares of the company's stock after selling 235,032 shares during the period. Jane Street Group LLC owned approximately 0.10% of Definitive Healthcare worth $513,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Point72 DIFC Ltd increased its position in shares of Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock valued at $42,000 after purchasing an additional 8,215 shares during the period. Intech Investment Management LLC bought a new stake in Definitive Healthcare in the 3rd quarter valued at $55,000. Sanctuary Advisors LLC acquired a new position in shares of Definitive Healthcare in the 2nd quarter valued at $85,000. Bleakley Financial Group LLC bought a new position in shares of Definitive Healthcare during the 3rd quarter worth about $74,000. Finally, Glenmede Trust Co. NA lifted its holdings in shares of Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after acquiring an additional 5,362 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 14.84% of the company's stock.

Definitive Healthcare Price Performance

Shares of DH stock traded up $0.07 during trading hours on Monday, reaching $4.43. 310,581 shares of the company were exchanged, compared to its average volume of 271,060. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The company has a market cap of $511.77 million, a price-to-earnings ratio of -1.43, a P/E/G ratio of 3.29 and a beta of 1.41. The stock's fifty day moving average is $4.37 and its two-hundred day moving average is $4.56. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. BTIG Research began coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price target on the stock. Stephens initiated coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They issued an "equal weight" rating and a $5.00 target price on the stock. Finally, Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Definitive Healthcare presently has a consensus rating of "Hold" and a consensus target price of $5.72.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.